AOD-9604 vs HGH Fragment 176-191: A Research Comparison

AOD-9604 and HGH Fragment 176-191 are both metabolic research fragments derived from the 176-191 region of human growth hormone; HGH Fragment 176-191 is the direct fragment, while AOD-9604 is a modified analog of it. At Peptide Hackers, researchers should focus on their structural relationship and demand per-batch documentation for identity confirmation.

The comparison of AOD-9604 vs HGH Fragment 176-191 is common due to their shared origin. Online discussions often conflate them, sometimes leading to unsupported claims. Researchers should carefully consider the structural relationship between the two peptides and verify compound identity through appropriate documentation.

This overview compares AOD-9604 and HGH Fragment 176-191, focusing on class, structure, and sourcing, which are key considerations for researchers.

Origin and Structural Relationship

Both AOD-9604 and HGH Fragment 176-191 are metabolic research fragments derived from human growth hormone, specifically the region of amino acids 176 to 191. HGH Fragment 176-191 represents the direct sequence of this region [1], while AOD-9604 is a modified analog with a specific structural alteration described in the literature (e.g., PubMed).

Their close structural relationship means both are studied in laboratory and animal models, with research findings not confirmed in humans.

Structural and Research Class Differences

	AOD-9604	HGH Fragment 176-191
Type	Modified HGH fragment analog	HGH-derived peptide fragment
Research class	HGH-derived metabolic research fragment	HGH-derived metabolic research fragment
Structure	Fragment 176-191 with a structural modification	Fragment of the HGH molecule, residues 176 to 191
Documentation to demand	Per-batch COA, HPLC, mass spec	Per-batch COA, HPLC, mass spec

It is important to note that the research class framing is for laboratory use only, drawn from how the compounds are described in the literature, and findings are not confirmed in humans.

Understanding HGH Fragment 176-191

HGH Fragment 176-191 serves as the foundational peptide from which AOD-9604 is derived, making it a key reference point for comparative research. For a closer look at HGH Fragment 176-191 on its own, see our what is HGH Fragment 176-191 overview. AOD-9604, as its modified analog, shares a similar metabolic research classification but features a distinct structural alteration.

Sourcing and Quality Considerations for Research

Sourcing high-quality research peptides requires careful vendor selection. Both AOD-9604 and HGH Fragment 176-191 are popular, which can attract suppliers who may not adhere to rigorous testing standards. Researchers should prioritize verifiable documentation over speculative claims about effects.

For each compound, researchers should demand a per-batch Certificate of Analysis (COA) available for review prior to purchase, demonstrating HPLC-verified purity of 99% or higher for the specific lot, mass spectrometry confirmation, and a lot number traceable to the purchased vial. Two related fragments look identical as lyophilized powder, so the documentation is the only reliable identity check you have.

Peptide Hackers carries both AOD-9604 and HGH Fragment 176-191 with that documentation on every batch, third-party tested through Janoshik. You can see a live Certificate of Analysis before you order, then pick up the same day in Los Angeles or Newport Beach or have it shipped.

All products are for laboratory research only. Not for human or veterinary use.

Frequently Asked Questions

What is the primary difference between AOD-9604 and HGH Fragment 176-191?

HGH Fragment 176-191 is a direct fragment of the human growth hormone molecule, specifically residues 176-191. AOD-9604 is a modified analog of this same fragment, meaning it has a slight structural alteration from the original sequence. Both are studied for their metabolic properties in research settings.

Why is documentation important when sourcing these research peptides?

Documentation, such as a Certificate of Analysis (COA), HPLC, and mass spectrometry data, is critical for verifying the identity, purity, and concentration of research peptides. Given their similar origins and appearance as lyophilized powders, reliable documentation is the primary method for researchers to confirm they have the correct compound and that it meets purity standards for their studies. This helps ensure the integrity and reproducibility of research findings.

Are AOD-9604 and HGH Fragment 176-191 approved for human use?

No, neither AOD-9604 nor HGH Fragment 176-191 are approved for human therapeutic use. They are strictly intended for laboratory research purposes only. All studies involving these compounds are preclinical, and their effects in humans have not been established.

Where can researchers find reliable information on peptide vendors?

Researchers can find reliable information on peptide vendors by looking for transparency in their testing protocols, availability of third-party Certificates of Analysis (COAs), and a clear track record. Resources like How to Verify a Research Peptide Vendor in 2026 (COA, HPLC, and Track Record) can provide a checklist for evaluating potential suppliers.

What are common challenges in sourcing research peptides?

Sourcing research peptides can present challenges, particularly with popular compounds like AOD-9604 and HGH Fragment 176-191. Researchers may encounter vendors who do not provide adequate documentation, leading to uncertainty about product identity and purity. It is crucial to prioritize vendors offering transparent, third-party verified Certificates of Analysis (COAs) for each batch. For further guidance on vendor selection, resources like Stranded by Peptide Sciences? A Checklist for Choosing Your Next Vendor can be helpful.

References

1. Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells — Drug Des Devel Ther (2022). PMID: 35783198